Cargando…
Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitum...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606592/ https://www.ncbi.nlm.nih.gov/pubmed/36313662 http://dx.doi.org/10.3389/fonc.2022.1022973 |
_version_ | 1784818330349076480 |
---|---|
author | Yang, Jiali Fu, Qiqi Jiang, Hui Li, Yinghua Liu, Muqing |
author_facet | Yang, Jiali Fu, Qiqi Jiang, Hui Li, Yinghua Liu, Muqing |
author_sort | Yang, Jiali |
collection | PubMed |
description | Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitumor therapeutic approach including photodynamic therapy (PDT), photothermal therapy (PTT), and photobiomodulation therapy (PBMT), has been widely applied in superficial skin tumor research and clinical treatment. OS is the typical deep tumor, and its phototherapy research faces great limitations and challenges. Surprisingly, pulse mode LED light can effectively improve tissue penetration and reduce skin damage caused by high light intensity and has great application potential in deep tumor research. In this review, we discussed the research progress and related molecular mechanisms of phototherapy in the treatment of OS, mainly summarized the status quo of blue light PBMT in the scientific research and clinical applications of tumor treatment, and outlooked the application prospect of pulsed blue LED light in the treatment of OS, so as to further improve clinical survival rate and prognosis of OS treatment and explore corresponding cellular mechanisms. |
format | Online Article Text |
id | pubmed-9606592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96065922022-10-28 Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy Yang, Jiali Fu, Qiqi Jiang, Hui Li, Yinghua Liu, Muqing Front Oncol Oncology Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitumor therapeutic approach including photodynamic therapy (PDT), photothermal therapy (PTT), and photobiomodulation therapy (PBMT), has been widely applied in superficial skin tumor research and clinical treatment. OS is the typical deep tumor, and its phototherapy research faces great limitations and challenges. Surprisingly, pulse mode LED light can effectively improve tissue penetration and reduce skin damage caused by high light intensity and has great application potential in deep tumor research. In this review, we discussed the research progress and related molecular mechanisms of phototherapy in the treatment of OS, mainly summarized the status quo of blue light PBMT in the scientific research and clinical applications of tumor treatment, and outlooked the application prospect of pulsed blue LED light in the treatment of OS, so as to further improve clinical survival rate and prognosis of OS treatment and explore corresponding cellular mechanisms. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606592/ /pubmed/36313662 http://dx.doi.org/10.3389/fonc.2022.1022973 Text en Copyright © 2022 Yang, Fu, Jiang, Li and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yang, Jiali Fu, Qiqi Jiang, Hui Li, Yinghua Liu, Muqing Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title | Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title_full | Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title_fullStr | Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title_full_unstemmed | Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title_short | Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
title_sort | progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606592/ https://www.ncbi.nlm.nih.gov/pubmed/36313662 http://dx.doi.org/10.3389/fonc.2022.1022973 |
work_keys_str_mv | AT yangjiali progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy AT fuqiqi progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy AT jianghui progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy AT liyinghua progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy AT liumuqing progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy |